Immunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.
Rebecca R. Boehman
Advertisement
Articles by Rebecca R. Boehman
Advertisement
Latest Updated Articles
Combating Advancing Cancers With CAR T-Cell TherapyPublished: September 8th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
2
OpEd: The Drug Enforcement Administration Needs a Chief Pharmacy Officer. Here’s Why
3
FDA Updates Boxed Warning for Cilta-Cel Following Reports of Immune Effector Cell–Associated Enterocolitis
4
Medetomidine: The Demon in the Illicit Fentanyl Supply
5
